Introduction
tients with chronic diseases, including rheumatoid arthritis (RA) [1] [2] [3] [4] [5] . Improvement of patients' QOL In the past two decades, assessment of health has become a major target of treatment. In general, status and quality of life (QOL) as an outcome health status and QOL of RA patients are substantialmeasure has become increasingly important in pa-ly impaired, whereas disease status as assessed by disease related variables does not reflect accurately the impact of the disease on psychological and social QOL have had little attention. Recently, we found Therefore, the aim of this study was to compare the impairment of health status and QOL in sarcoidosis impact on QOL of RA and sarcoidosis. Recently, we patients [7, 8] . No relationship of routinely performed showed that QOL in symptomatic sarcoidosis papulmonary function tests and serum angiotensin tients was more seriously impaired than QOL in converting enzyme (sACE) with health status and patients without current symptoms [8] . We hypoth-QOL was found [7, 8] .
esized that QOL would be impaired in RA as well as Sarcoidosis and rheumatoid arthritis (RA) have sarcoidosis compared to healthy controls. Sarcoidosis several sequelae in common. Both are inflammatory patients were expected to have better QOL than RA disorders of unknown etiology. In both disorders the patients. Especially with respect to pain and levels of mode of onset is variable and they both regularly independence we expected a more serious impairoccur in relatively young people. The clinical course ment of QOL in the RA patients. With respect to in both disorders is rather unpredictable, ranging fatigue no difference between the patient groups was from spontaneous remission to rapid progression or a expected. Therefore, in the present study QOL in more chronic course. Some immunologic disturbance active RA was compared with QOL of symptomatic is thought to play a central role in the pathogenesis sarcoidosis patients. For this purpose a broad-ranging of sarcoidosis [9] as well as in RA [10] . Mani-generic QOL instrument, the World Health Organizafestations of RA are primarily in the joints, but tion Quality of Life assessment instrument systemic symptoms and extra-articular inflammation (WHOQOL-100) [19] , was used. may be present as well. In RA, as in sarcoidosis, pulmonary involvement with interstitial pneumonitis or fibrosis, however only occasionally, may occur Materials and methods [11, 12] . In sarcoidosis, symptoms vary considerably depending on the organ involvement. Patients with Patients sarcoidosis may present with aspecific symptoms also present in RA such as fatigue, arthralgia, and A group of RA patients (n 5 35) was recruited muscle pain. In a previous study, we found that in aselectively from consecutive patients with RA not about 5% of patients with sarcoidosis, the symptoms in remission visiting the Outpatient Department of were initially attributed to a RA [13] [20] . The patients were assessed rather by disease-specific health status clinically assessed by a rheumatologist, who commeasures [5,15-17] than by subjective QOL mea-pleted a questionnaire with the clinical characterissures. Health status measures assess mainly func-tics: disease duration, functional class according to tional status, whereas QOL instruments assess the Steinbrocker [21] , current serum markers (erythroindividuals' subjective perception of their life. When cyte sedimentation rate (ERS) and C-reactive protein using health status measures, it would be a mistake (CRP)), 28 swollen joint index, and current medicato equate lower levels of functioning with lower tion. At the same visit the patient completed the QOL. For this conclusion would contrast with find-WHOQOL-100 [19] . ings in QOL research reflecting high perceived QOL
The sarcoidosis patient group was recruited from in spite of low levels of functioning [18] .
eight Dutch hospitals (Rijnstate Hospital, Arnhem; To the best of our knowledge, there exist no Academic Hospital St Radboud, Nijmegen; Rehabilicomparative studies on QOL in RA and other tation Center Dekkerswald, Nijmegen; District chronic inflammatory disorders such as sarcoidosis.
Hospital Middle Twente, Hengelo; St. Jans-Hospital, pleted the WHOQOL-100. In addition, the physician a asked them whether they had any of the following Data are means (SD); CRP 5 C-reactive protein, normal levels , 9 U / l; ESR 5 erythrocyte sedimentation rate; DMARDs 5 complaints: fatigue, dyspnea, coughing, arthralgia, or disease modifying anti-rheumatic drugs. erythema nodosum. Twenty-seven out of the 64 studied sarcoidosis patients reported no actual symptoms, whereas 37 patients appeared to suffer from mg / day, one with 15 mg / day, and of one patient one or more symptom(s). In order to be able to information on the dose was missing. Only one compare the impact of symptoms between sar-patient did not receive disease modifying anticoidosis patients and the studied RA patients, who rheumatic drugs (DMARDs) at the time of the study. were not in remission, only sarcoidosis patients with Ten patients were currently treated with Methothrecurrent symptoms related to their disorder (n 5 37) xate, nine with Sulphasalazine, four with Azathiowere included in the present study. Using the patient prine, three with Penicillamine, two with Hydroxyrecord, the values of serum angiotensin converting chloroquine, one with Auromyosis, and one patient enzyme (sACE) levels and the pulmonary function received the combination Sulphasalazine and Metotests were obtained from the visit closest to the threxate at the time of the study. session in which the questionnaires were completed.
The characteristics of the sarcoidosis patients are Furthermore, 240 control persons were recruited summarized in Table 3 . The sarcoidosis patients who were willing to participate in a study on QOL. From the group of persons who returned a completed Table 3 test-booklet (n 5 178; 74.2%), healthy control sub-Characteristics of the sarcoidosis patient group jects (n 5 37) were selected on the basis of gender roids; all these patients received prednisolone. One second; T L,CO 5 transfer factor of the lung for carbon monoxide; patient was treated with 7.5 mg / day, two with 10 sACE 5 serum angiotensin converting enzyme. reported the following symptoms: fatigue in 28, (60-80%); (3) moderate decrease (40-60%); (4) dyspnea in 15, arthralgia in 11, cough in six patients, severe decrease ( , 40%), of the values predicted. and erythema nodosum in one patient. With respect to the pulmonary function tests, eight of the sar-Statistical methods coidosis patients (21.6%) showed a mildly decreased forced expiration volume in one second (FEV ), and 1 Data are expressed as mean (SD) and, if appro-15 patients showed a decreased transfer factor of the priate, as mean with range. Statistical differences in lung for carbon monoxide (T L,CO). In 12 of the age and gender between patient groups were studied patients the T L,CO was mildly decreased and in three 2 using Student's t-tests and x -tests. Pearson correlapatients it was moderately decreased, according to tion coefficients were used. Significance was acthe American Medical Association classes.
cepted with P-values , 0.05. Furthermore, data were analyzed using analysis of variance (ANOVA) with Questionnaire age and gender as covariates between groups. Within the RA group one-way analyses of variance were Both patient groups and the healthy controls used. In ANOVA, significance was accepted with completed the World Health Organization Quality of P-values , 0.01 due to the number of analyses. All Life assessment instrument, WHOQOL-100, (Dutch analyses were performed using the Statistical Packversion) [19] . This is a cross-culturally developed age for Social Science (SPSS) for Windows [25] . generic multidimensional QOL measure that has been simultaneously developed in 15 centres around the world, e.g. in France, Russia, USA, Panama, Zimbabwe, Japan, Thailand, and The Netherlands
Results [22] . It consists of 100 items assessing 24 facets of QOL within six domains (Physical Health, Psycho-
The RA patients were significantly older than the logical Health, Level of Independence, Social Rela-sarcoidosis patients (P , 0.001). [19, 23] .
df 5 2, P , 0.001), Activities of Daily Living (F 5 18.1; df 5 2, P , 0.001), and Working Capacity (F 5 Pulmonary function tests 18.5; df 5 2, P , 0.001) were low in the two patient groups compared to the healthy controls. Pulmonary function measurements of the sar-In the domains Physical Health (F 5 18.1; df 5 2, coidosis patients included the FEV (Compactbody, P , 0.001) as well as Level of Independence (F 5 1 Jaeger, Wurzburg, Germany). The best measure of 26.6; df 5 2, P , 0.001) and its facet Dependence on three efforts was selected. All volumes are expressed Medication or Treatment (F 5 41.2; df 5 2, P , as percentages of the reference values [24] . The 0.001) all three groups scored significantly different T L,CO was measured using the single breath method from each other, the healthy controls having thë (Masterlab, Jaeger, Wurzburg, Germany). Four highest QOL in these areas and the RA group the ranges of FEV and T L,CO levels were classified lowest. Furthermore, the group of RA patients scored 1 according to the American Medical Association worse on the facets Pain and Discomfort (F 5 16.1; classes: (1) normal ( . 80%); (2) mild decrease df 5 2, P , 0.001) and Mobility (F 5 6.9; df 5 2, P , 0.01) than the sarcoidosis patients and the P , 0.05) as well as Spirituality / Religion / Personal healthy group.
Beliefs (r 5 2 0.41, P , 0.05) and the doses of For the RA patients we found a significant correla-systemic corticosteroids. tion between the evaluative facet Overall QOL and On the facet level, Energy and Fatigue correlated General Health and the facet Pain and Discomfort with the number of courses with DMARDs in the (r 5 2 0.65, P , 0.001). Moreover, a relationship past (r 5 2 0.50, P , 0.01), and the doses of syswas found between the facet Energy and Fatigue and temic corticosteroids (r 5 2 0.39, P , 0.05). Morethe facet Pain and Discomfort (r 5 2 0.69, P , over, RA patients with elevated CRP levels showed 0.001). (Note, that for the facet Pain and Discomfort, even lower scores for Energy and Fatigue (t 5 2.95, in contrast to most other facets, higher scores mean a df 5 12, P 5 0.012) than those with normal CRP. tion, no relationship was found between gender, Discussion duration of the disease, and the current medication with DMARDs and patients' QOL. Fig. 1 shows the Generally, parameters of disease activity or prorelationship between the functional class and the gression in RA are measured by the disease activity domains Physical Health, Level of Independence, score (DAS). The DAS has shortcomings with and the evaluative facet Overall Quality of Life and respect to the subjective feeling the RA patient has. General Health. In Fig. 2 
., the relationship between
In this study, we compared quality of life (QOL) in the facets of these two domains and the functional RA with QOL in sarcoidosis using the WHOQOLclass is illustrated.
100. The results showed that compared with healthy The domain Psychological Health (F 5 5.4, df 5 control subjects, QOL was impaired in both RA 2; P , 0.05), and its facets Self-Esteem (F 5 9.0, patients and sarcoidosis patients in many aspects of df 5 2; P , 0.001) and Negative Feelings (F 5 7.5, daily life. Compared to sarcoidosis patients, the df 5 2; P , 0.01) were related to positivity of the impairment of QOL in RA patients was more severe rheumatoid factor (RF). Scores for both facets were and included more aspects of daily life. higher in patients with positivity for RF than in those Both patient groups felt anergic and suffered from with a positivity for APF or seronegativity for RF, fatigue. Recurrent or persistent fatigue is a feature of indicating that patients with a positive RF had a many acute or chronic inflammatory conditions. better psychological health, more self-esteem, and Fatigue is generally recognized as a subjective less negative feelings. feature in RA not being in clinical remission [26] . For the sarcoidosis patients, no relationships were Crosby found in a patient group with RA that more found between physiological measures, that is sACE than 50% of patients suffered from fatigue and levels as well as pulmonary function tests, and QOL.
constant lack of energy [27] . Furthermore, in another study she demonstrated a correlation of pain, frag-found, that patients with RA have to cope simulmented sleep, and functional ability with fatigue in taneously with pain, limitations and dependence and RA patients [28] . In the present study, pain and that all three factors were negatively related to QOL fatigue were interrelated in the RA patients. How- [32] . Moreover, depressive symptoms are more ever, no interrelationships of pain and fatigue with frequent in patients with RA than in healthy controls, sleep were found, although all three aspects were even after controlling for criterion contamination significantly impaired. In sarcoidosis, the symptom [31, 33] . In the present study, the RA patients as a fatigue has received little attention in literature [29] .
group were not impaired with respect to their Recently, we found lower levels of energy and more psychological health. However, patients with lower fatigue in a group of sarcoidosis patients compared levels of energy showed more impairment of their to healthy controls. This finding was not associated psychological health. In rheumatology research, the with current symptoms; it appeared to be present also negative affect component of QOL has been emphain patients who initially had reported no symptoms sized [31] . In the present study, RA patients did not [8] . In another study, we found besides reduced have more negative feelings than sarcoidosis patients respiratory muscle strength and respiratory muscle and healthy controls. However, patients with endurance, an interrelationship between the symptom seropositivity for rheumatoid factor (RF) showed fatigue and decreased expiratory muscle strength better psychological health, less negative feelings, [30] . and a better self-esteem compared with positivity for RA can have a negative effect on affective, APF. Fewer psychopathological tendencies in pabehavioral, and social functioning of patients [31] . tients with positivity for RF than in those with Studying psychological stressors in RA, others have seronegativity for RF have been reported before [34] .
Also the sarcoidosis patients included in this study asking patients, whether they have complaints [8] . were not impaired in their psychological health. We
The WHOQOL-100 facet Energy and Fatigue apfound no relationship between psychological health pears to be sensitive for the assessment of fatigue in and fatigue. With respect to depressive symptoms in RA patients as well. sarcoidosis patients, we found in a previous study Physiological measures such as ESR and the that patients with current symptoms experienced current medication as well as medication in the past more depressive symptoms than asymptomatic pa-were related to only a few aspects of QOL. As tients [7] . discussed above, elevated CRP levels correlated with In the present study, the QOL in both patient patients' pain and discomfort. No relationship was groups was impaired mainly with respect to aspects found between duration of the disease and QOL. In of physical health and level of independence, as well general, non-significant correlations were found beas general health and overall QOL. As discussed tween QOL and the routinely performed physiologiabove, with respect to fatigue and sleeping problems, cal measures. These results are in line with other the two patient groups did not differ significantly studies that have shown that disease status in RA, from each other. Also difficulties performing ac-assessed by the routinely performed measures of tivities of daily living and work were equally im-physical health, did not reflect the impact of RA on paired in both patient groups. In addition, the RA psychosocial well-being [38]. Self-reported low patients were impaired in their mobility. Also pain physical well-being, however, was associated with and discomfort appeared to be a major problem only more depressive feelings [6] . Other subjective stresin RA patients. This could be expected, as chronic sors such as perceived limitation and dependence and acute pain is known to be the major consequence were found only weakly related to traditionally used of this disorder [31, 32] . Surprisingly, no relationship disease status measures [32] . was found between the levels of pain of RA patients For the sarcoidosis patients no relationship beassessed by the WHOQOL-100 and any of the tween pulmonary function tests such as FEV and 1 physiological measures of disease severity. In con-T L,CO and the WHOQOL-100 scores were found. trast, Meenan et al. found for the AIMS pain scale Also health status was not related to duration of the relationships with criteria of disease severity such as disease and routinely performed tests such as puljoint count [35] . However, the AIMS is a health monary function tests and serum angiotensin constatus measure and the questions are closer related to verting enzyme (sACE) levels, respectively, as we objective measures than the WHOQOL-100 items.
showed in a previous study [7] . However, as men-The questions of the latter assess, e.g. to what extent tioned above, fatigue was found related to higher the patient has 'difficulties to cope with pain or levels of CRP in sarcoidosis patients [37] . Although discomfort', 'worries about pain or discomfort', and the impairment of QOL was more severe in the RA measure the 'extent that pain keeps you from doing patients, QOL was considerably impaired in the what you must do'. These questions assess rather the sarcoidosis patients as well. When only considering patient's subjective perception. The impairment the the pulmonary function tests, one would expect only patient perceives by the pain is not necessarily mild impairment of QOL in these sarcoidosis parelated to measures such as functional status or tients, as these tests were normal in most patients, or swollen joint count.
showed only mild impairment.
RA patients with elevated CRP levels had low
The present study has a couple of limitations. levels of energy and more fatigue. This is in line Disease severity as assessed by the different, routinewith other studies, in which improvement of fatigue ly performed physiological measures for both discoincided with a descend of CRP levels after treat-orders are not directly comparable. Moreover, the ment [36]. Previously, we found a relationship disease duration of the RA patients was longer than between fatigue and CRP levels for sarcoidosis that of the sarcoidosis patients. Although one may patients as well [37] . Moreover, we found that in hypothesize that duration of the disease influences sarcoidosis patients, the symptom fatigue is assessed QOL, this was clearly not the case in both patient more accurately by the WHOQOL-100 than by only groups. In addition, the RA patients were signifi- disease impact on the quality of life was more severe
